Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites
暂无分享,去创建一个
[1] G. Defossez,et al. Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing , 2021, BMC Cancer.
[2] P. Dickman,et al. Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis , 2020, Journal of internal medicine.
[3] M. Bøgsted,et al. On estimating the time to statistical cure , 2020, BMC Medical Research Methodology.
[4] Ahmedin Jemal,et al. Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[5] D. Serraino,et al. Major patterns of cancer cure: Clinical implications. , 2019, European journal of cancer care.
[6] V. Jooste,et al. Time-to-cure and cure proportion in solid cancers in France. A population based study. , 2019, Cancer epidemiology.
[7] V. Jooste,et al. Time trends and short term projections of cancer prevalence in France. , 2018, Cancer epidemiology.
[8] J. Barnholtz-Sloan,et al. A comparison of relative survival and cause‐specific survival methods to measure net survival in cancer populations , 2018, Cancer medicine.
[9] V. Jooste,et al. A new approach to estimate time-to-cure from cancer registries data. , 2018, Cancer epidemiology.
[10] N. Voirin,et al. Survival of solid cancer patients in France, 1989–2013: a population-based study , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[11] B. Rachet,et al. Analysing population-based cancer survival – settling the controversies , 2016, BMC Cancer.
[12] P. Grosclaude,et al. [Prostate cancer incidence and mortality trends in France from 1980 to 2011]. , 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[13] M. Federico,et al. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] J. Ferlay,et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008 , 2013, International journal of cancer.
[15] Paul C. Lambert,et al. Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model , 2011 .
[16] P C Lambert,et al. Estimating the crude probability of death due to cancer and other causes using relative survival models , 2010, Statistics in medicine.
[17] Jacques Ferlay,et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research , 2010, Acta oncologica.
[18] Paul C. Lambert,et al. Further Development of Flexible Parametric Models for Survival Analysis , 2009 .
[19] Paul C Lambert,et al. Flexible parametric models for relative survival, with application in coronary heart disease , 2007, Statistics in medicine.
[20] P. Royston,et al. Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects , 2002, Statistics in medicine.